CN101461841B - Chinese patent medicine for treating prostatoplasia - Google Patents

Chinese patent medicine for treating prostatoplasia Download PDF

Info

Publication number
CN101461841B
CN101461841B CN2009100366407A CN200910036640A CN101461841B CN 101461841 B CN101461841 B CN 101461841B CN 2009100366407 A CN2009100366407 A CN 2009100366407A CN 200910036640 A CN200910036640 A CN 200910036640A CN 101461841 B CN101461841 B CN 101461841B
Authority
CN
China
Prior art keywords
parts
chinese patent
patent medicine
radix
radix notoginseng
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100366407A
Other languages
Chinese (zh)
Other versions
CN101461841A (en
Inventor
黄卫忠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009100366407A priority Critical patent/CN101461841B/en
Publication of CN101461841A publication Critical patent/CN101461841A/en
Application granted granted Critical
Publication of CN101461841B publication Critical patent/CN101461841B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a Chinese patent drug for treating prostatoplasia. The Chinese patent drug comprises the following raw materials: 250 to 750 portions of pseudo-ginseng, 200 to 400 portions of Buthus martensi kirsch and 250 to 750 portions of kuh-seng. In the Chinese patent drug, the pseudo-ginseng has the functions of activating blood circulation and dissipating blood stasis, the Buthus martensi kirsch has the functions of detoxifying and resolving masses, and the kuh-seng has the function of clearing dampness and heat in liver and gallbladder and also has the diuretic effect, so that the Chinese patent drug can effect a radical cure on the prostatoplasia disease, avoid surgery, and relieve pain of patients.

Description

A kind of Chinese patent medicine for the treatment of prostatic hyperplasia
Technical field
The present invention relates to a kind of Chinese patent medicine, particularly a kind of Chinese patent medicine for the treatment of prostatic hyperplasia.
Background technology
Prostatic hyperplasia be in, the commonly encountered diseases and the frequently-occurring disease of elderly men.According to many families statistics such as America and Europes, in elderly men, the prostatic hyperplasia sickness rate is up to more than 80%; Domesticly also reach more than 50%.In recent years, along with growth in the living standard, the development of Medical Technology, the average life of population also constantly prolongs, and this is the trend that rises gradually with regard to the sickness rate that has caused prostatic hyperplasia.Prostatic hyperplasia can cause the controlled micturition difficulty, and is not to the utmost dripping, and urine urgency-frequency, nocturia increase etc., further develop to cause urine retention, and renal insufficiency, complication such as serious urinary tract infection have a strong impact on quality of life of patient.Though operation is a treatment means the most completely, but most patients are worn with age, when treatment, must consider to block the whole body situation of degree simultaneously, especially whether the heart, lung, renal function can tolerate operation, the incidence rate of operation and complication is also higher once more simultaneously, for slight hypertrophy and older and can not tolerate surgery person, Drug therapy remains the important method of at first selecting.Yet the effect of Western medicine and Chinese patent medicine now is limited, is difficult to reach recovery from illness.
Summary of the invention
The technical problem to be solved in the present invention provides a kind of Chinese patent medicine for the treatment of prostatic hyperplasia, can effect a radical cure prostatic hyperplasia, needn't operative treatment.
In order to solve the problems of the technologies described above, a kind of Chinese patent medicine for the treatment of prostatic hyperplasia of the present invention, the raw material that described Chinese patent medicine is made is made of following component: 250~750 parts in Radix Notoginseng, 200~400 parts of Scorpios, 250~750 parts of Radix Sophorae Flavescentiss, 200~400 parts of Fructus Cnidiis, 200~400 parts of field dobbers, 200~500 parts of Herba Lysimachiaes, 200~500 parts in Talcum, 50~100 parts in Radix Glycyrrhizae, wherein, the manufacture method of described Chinese patent medicine is:
A) Scorpio, Radix Sophorae Flavescentis, Fructus Cnidii, field dobber, Herba Lysimachiae, Talcum and Radix Glycyrrhizae are mixed with water decocted 2 hours, extract decocting liquid for the first time, add decocting in the recrement again and boiled 1.5 hours, extract the decocting liquid second time;
B) first and second time decocting liquid is mixed, be concentrated into thick paste;
C) Radix Notoginseng is ground into the Radix Notoginseng fine powder, sieves;
D) step b gained thick paste is mixed with step c gained Radix Notoginseng fine powder, drying, final powder is broken into Powdered.
The invention has the beneficial effects as follows: Radix Notoginseng blood circulation promoting and blood stasis dispelling in this Chinese patent medicine, the Scorpio detoxicating and resolving stagnation of pathogens, the source is damp and hot on the Radix Sophorae Flavescentis liver heat removing gallbladder a diuresis in addition, and the disease that can effect a radical cure prostatic hyperplasia can be avoided operation, alleviates patient's misery.
The specific embodiment
A kind of Chinese patent medicine for the treatment of prostatic hyperplasia of the present invention, the raw material that described Chinese patent medicine is made comprises: 250~750 parts in Radix Notoginseng, 200~400 parts of Scorpios, 250~750 parts of Radix Sophorae Flavescentiss.
The raw material that described Chinese patent medicine is made also comprises: 200~400 parts of Fructus Cnidiis, 200~400 parts of field dobbers, 200~500 parts of Herba Lysimachiaes, 200~500 parts in Talcum, 50~100 parts in Radix Glycyrrhizae.
The manufacture method of described Chinese patent medicine is:
A) Scorpio, Radix Sophorae Flavescentis, Fructus Cnidii, field dobber, Herba Lysimachiae, Talcum and Radix Glycyrrhizae are mixed with water decocted 2 hours, extract decocting liquid for the first time, add decocting in the recrement again and boiled 1.5 hours, extract the decocting liquid second time;
B) first and second time decocting liquid is mixed, be concentrated into thick paste;
C) Radix Notoginseng is ground into the Radix Notoginseng fine powder, sieves;
D) step b gained thick paste is mixed with step c gained Radix Notoginseng fine powder, drying, final powder is broken into Powdered.
Above-mentioned finished medicines is added different adjuvants can be made into tablet, pill, capsule, electuary and oral liquid.Radix Notoginseng blood circulation promoting and blood stasis dispelling in this Chinese patent medicine, the Scorpio detoxicating and resolving stagnation of pathogens, the source is damp and hot on the Radix Sophorae Flavescentis liver heat removing gallbladder a diuresis in addition, be aided with Fructus Cnidii, field dobber in above-mentioned component, the effect of supporing yang the kidney invigorating can be arranged, Herba Lysimachiae, Talcum, Radix Glycyrrhizae have the effect of antiinflammatory diuretic, make the component of Chinese patent medicine more reasonable, can effect a radical cure the disease of prostatic hyperplasia, can avoid operation, alleviate patient's misery.Two application examples below are provided:
1. Wu, the man, 65 years old, on February 12nd, 2008 went to a doctor, and the patient began to occur frequent micturition, urgent micturition, nocturia increased frequency before 2 years.Once took Western medicine, Chinese patent drugs for treatment, but doing well,improving is not obvious.B ultrasonic shows prostate 5.0cm * 4.5cm, the rectal touch prostatauxe, and matter is harder, and disappearence of central groove has the tenderness sense.Take the each 2.5g medicated powder of this prescription and take after mixing it with water, every day three times, the urine condition improved is good after 10 days, and is normal fully after 20 days, does ultrasound diagnosis after continuing to take medicine 10 days, prostate 3.8cm * 3.5cm, and rectal touch prostate size is normal, quality deliquescing, no tenderness sense.
2. Zhang, 70 years old, on October 25th, 2007 examined.Sufferer is surplus with the conduit urethral catheterization moon, Western medicine, Chinese patent medicine therapeutic alliance therebetween, but do not feel any better, ultrasound diagnosis prostate 5.7cm * 4.8cm, the rectal touch prostatauxe, matter is harder, and disappearence of central groove has the tenderness sense.Take this prescription, every day three times, each 2.5g medicated powder is taken after mixing it with water.Urine compressing catheter is deviate from automatically after 15 days, and urine is normal after taking medicine 30 days, does ultrasound diagnosis after adding 10 days, prostate 4.0cm * 3.7cm, and rectal touch prostate size is normal, the quality deliquescing, no tenderness sense is followed the trail of and was not seen recurrence in 1 year.

Claims (1)

1. Chinese patent medicine for the treatment of prostatic hyperplasia, it is characterized in that the raw material that described Chinese patent medicine is made is made of following component: 250~750 parts in Radix Notoginseng, 200~400 parts of Scorpios, 250~750 parts of Radix Sophorae Flavescentiss, 200~400 parts of Fructus Cnidiis, 200~400 parts of field dobbers, 200~500 parts of Herba Lysimachiaes, 200~500 parts in Talcum, 50~100 parts in Radix Glycyrrhizae, wherein, the manufacture method of described Chinese patent medicine is:
A) Scorpio, Radix Sophorae Flavescentis, Fructus Cnidii, field dobber, Herba Lysimachiae, Talcum and Radix Glycyrrhizae are mixed with water decocted 2 hours, extract decocting liquid for the first time, add decocting in the recrement again and boiled 1.5 hours, extract the decocting liquid second time;
B) first and second time decocting liquid is mixed, be concentrated into thick paste;
C) Radix Notoginseng is ground into the Radix Notoginseng fine powder, sieves;
D) step b gained thick paste is mixed with step c gained Radix Notoginseng fine powder, drying, final powder is broken into Powdered.
CN2009100366407A 2009-01-09 2009-01-09 Chinese patent medicine for treating prostatoplasia Expired - Fee Related CN101461841B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100366407A CN101461841B (en) 2009-01-09 2009-01-09 Chinese patent medicine for treating prostatoplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100366407A CN101461841B (en) 2009-01-09 2009-01-09 Chinese patent medicine for treating prostatoplasia

Publications (2)

Publication Number Publication Date
CN101461841A CN101461841A (en) 2009-06-24
CN101461841B true CN101461841B (en) 2011-02-16

Family

ID=40802776

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100366407A Expired - Fee Related CN101461841B (en) 2009-01-09 2009-01-09 Chinese patent medicine for treating prostatoplasia

Country Status (1)

Country Link
CN (1) CN101461841B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107362253A (en) * 2017-06-20 2017-11-21 苏州市李良济健康产业有限公司 A kind of preparation method for the health products for improving fecundity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294013A (en) * 1999-10-26 2001-05-09 马俊杰 Medicine for treating prostatic hyperplasia
CN1682954A (en) * 2005-03-14 2005-10-19 庹元斌 Chinese medicine preparation for treating prostatic hyperplasia
CN1961955A (en) * 2006-11-15 2007-05-16 王信锁 Chinese medicinal formulation for treating hyperplasia of prostate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294013A (en) * 1999-10-26 2001-05-09 马俊杰 Medicine for treating prostatic hyperplasia
CN1682954A (en) * 2005-03-14 2005-10-19 庹元斌 Chinese medicine preparation for treating prostatic hyperplasia
CN1961955A (en) * 2006-11-15 2007-05-16 王信锁 Chinese medicinal formulation for treating hyperplasia of prostate

Also Published As

Publication number Publication date
CN101461841A (en) 2009-06-24

Similar Documents

Publication Publication Date Title
CN100349594C (en) Obstruction dredging wine
CN101406635B (en) Chinese medicine decoction for treating stranguria and eliminating stone
CN101757566A (en) Traditional Chinese medicine composition for treating colon cancer and preparation method thereof
CN101862428B (en) Chinese medicament for treating benign prostatic hyperplasia
CN102512630A (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN101732602B (en) Medicament for treating calculi and preparation method thereof
CN101810823B (en) Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine
CN104173782A (en) Medicine treating urinary calculi
CN101461841B (en) Chinese patent medicine for treating prostatoplasia
CN103083617A (en) Traditional Chinese medicine for treating hyperplasia of prostate
CN103393909B (en) Chinese medicinal preparation for treating biliary calculus with cholecystitis
CN102335311A (en) Decoction for treating intestinal obstruction, and application thereof
CN102000181A (en) Chinese traditional medicine composition for treating diarrhea and method for preparing medicament from Chinese traditional medicine composition
CN102205002B (en) Traditional Chinese medicine for treating intestinal cancer
CN101375965B (en) Chinese medicine honeyed bolus for treating recurrent psoriasis in progressive stage
CN101259214A (en) Medicine for treating hyperplasia of mammary glands
CN101411856A (en) Medicament for treating osteoproliferation
CN103720949A (en) Capsule for relieving constipation and clearing bowels and preparation method thereof
CN102698130A (en) Traditional Chinese medicine extract for treating postoperative intestinal adhesion
CN101229281B (en) Medicine for treating rheumatoid arthritis
CN101757137A (en) Medication for treating mixed hemorrhoids and preparation method thereof
CN1850157B (en) Health-care for resisting hyperplasia of mammary glands
CN105194526A (en) Traditional Chinese medicine for treating hepatic calculi
CN101152300A (en) Traditional Chinese medicine for treating stasis type intestinal obstruction
CN101703713B (en) Chinese medicinal prescription for treating avascular necrosis of femoral head and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110216

Termination date: 20150109

EXPY Termination of patent right or utility model